Holen Sie sich die Stockscreener-App
60.25
0.23%
0.14
Handel nachbörslich:
60.55
0.30
+0.50%
Schlusskurs vom Vortag:
$60.11
Offen:
$59.95
24-Stunden-Volumen:
1.08M
Relative Volume:
0.46
Marktkapitalisierung:
$8.25B
Einnahmen:
$550.17M
Nettoeinkommen (Verlust:
$201.35M
KGV:
60.25
EPS:
1
Netto-Cashflow:
$232.07M
1W Leistung:
-2.11%
1M Leistung:
+5.04%
6M Leistung:
+8.52%
1J Leistung:
+113.50%
1-Tages-Spanne:
$59.51
$61.35
1-Wochen-Bereich:
$59.24
$63.24
52-Wochen-Spanne:
$25.00
$85.21
Doximity Inc Stock (DOCS) Company Profile
Firmenname
Doximity Inc
Sektor
Branche
Telefon
(650) 549-4330
Adresse
500 THIRD STREET, SAN FRANCISCO
Vergleichen Sie DOCS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
60.25 | 11.54B | 550.17M | 201.35M | 232.07M | 1.00 |
|
VEEV
Veeva Systems Inc
|
281.00 | 46.13B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
58.01 | 10.01B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
97.08 | 8.42B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.97 | 6.64B | 906.14M | -52.62M | 89.62M | -0.3621 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-09 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-06-02 | Hochstufung | BTIG Research | Neutral → Buy |
| 2025-02-07 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-02-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-12-20 | Eingeleitet | Stephens | Equal-Weight |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-11-15 | Eingeleitet | Goldman | Neutral |
| 2024-11-14 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-13 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2024-11-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-11-08 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-10-15 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-08-09 | Hochstufung | Needham | Hold → Buy |
| 2024-07-18 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-04-25 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2024-01-02 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-08-09 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-08-09 | Herabstufung | Needham | Buy → Hold |
| 2023-08-03 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-05-01 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-01-06 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-10-31 | Eingeleitet | Wells Fargo | Overweight |
| 2022-10-24 | Eingeleitet | Evercore ISI | In-line |
| 2022-10-13 | Eingeleitet | BTIG Research | Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-08-05 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-07-28 | Eingeleitet | Berenberg | Buy |
| 2022-05-18 | Bestätigt | BofA Securities | Neutral |
| 2022-05-18 | Bestätigt | Goldman | Buy |
| 2022-05-18 | Bestätigt | Guggenheim | Buy |
| 2022-05-18 | Bestätigt | Jefferies | Buy |
| 2022-05-18 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-05-18 | Bestätigt | Needham | Buy |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-04-04 | Eingeleitet | BofA Securities | Neutral |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2021-12-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-11-17 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-11-10 | Bestätigt | Canaccord Genuity | Buy |
| 2021-11-10 | Bestätigt | Goldman | Neutral |
| 2021-11-10 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2021-11-10 | Bestätigt | Needham | Buy |
| 2021-11-10 | Bestätigt | Piper Sandler | Overweight |
| 2021-08-26 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-07-19 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-07-19 | Eingeleitet | Goldman | Neutral |
| 2021-07-19 | Eingeleitet | JP Morgan | Overweight |
| 2021-07-19 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-07-19 | Eingeleitet | Piper Sandler | Overweight |
| 2021-07-19 | Eingeleitet | Raymond James | Outperform |
| 2021-07-19 | Eingeleitet | SVB Leerink | Outperform |
| 2021-07-19 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Doximity Inc Aktie (DOCS) Neueste Nachrichten
Doximity, Inc. (NASDAQ:DOCS) Position Trimmed by Emergence GP Partners LLC - MarketBeat
Doximity Rides on Telehealth Demand: Will This Drive Sales Further? - MSN
Cerity Partners LLC Lowers Holdings in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity (NASDAQ:DOCS) Given New $61.00 Price Target at Truist Financial - MarketBeat
Doximity Inc. Stock Analysis and ForecastBreakthrough profit margins - jammulinksnews.com
Los Angeles Capital Management LLC Sells 145,242 Shares of Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
What drives Doximity Inc. stock priceUnmatched profit potential - Autocar Professional
Dakota Wealth Management Purchases New Position in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Is Doximity Inc. a good long term investmentFree Capital Efficiency Planning - Autocar Professional
What analysts say about Doximity Inc. stockConsistent double returns - Autocar Professional
Doximity (NASDAQ:DOCS) Stock Price Down 3.7%Here's What Happened - MarketBeat
Doximity’s SWOT analysis: digital health leader’s stock faces growth challenges By Investing.com - Investing.com South Africa
Doximity’s SWOT analysis: digital health leader’s stock faces growth challenges - Investing.com Nigeria
Doximity, Inc. (NASDAQ:DOCS) Receives $64.42 Consensus Target Price from Brokerages - MarketBeat
Doximity Poll: Yale Psychiatry Residency Program Ranks #3 Nationally - Yale School of Medicine
Edgestream Partners L.P. Takes Position in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Nisa Investment Advisors LLC Decreases Stock Position in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity Stock: A Deep Dive Into Analyst Perspectives (14 Ratings) - Benzinga
Doximity to Release Fiscal 2026 First Quarter Results on August 7, 2025 - Business Wire
Woodward Diversified Capital LLC Acquires New Holdings in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Rice Hall James & Associates LLC Has $25.24 Million Position in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
KeyCorp Forecasts Strong Price Appreciation for Doximity (NASDAQ:DOCS) Stock - MarketBeat
Axxcess Wealth Management LLC Makes New $254,000 Investment in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Bank of New York Mellon Corp Has $66.03 Million Holdings in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity (DOCS) Rises Higher Than Market: Key Facts - Yahoo Finance
Why Doximity Inc. stock attracts strong analyst attentionGrowth Stock Monitor - beatles.ru
Do Options Traders Know Something About Doximity Stock We Don't? - Yahoo Finance
Principal Financial Group Inc. Grows Holdings in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity (NASDAQ:DOCS) Shares Gap UpHere's Why - MarketBeat
Doximity, Inc. (NASDAQ:DOCS) Director Regina M. Benjamin Sells 5,000 Shares - MarketBeat
Teacher Retirement System of Texas Decreases Stake in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity (NASDAQ:DOCS) Upgraded by Evercore ISI to Outperform Rating - MarketBeat
Doximity, Inc. Long-Term Shareholder Announcement: Johnson - GlobeNewswire
Doximity Shares Rise After Upgrade From Evercore ISI - MarketScreener
Why Doximity (DOCS) Stock Is Up Today - Yahoo Finance
This Microsoft Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday - Benzinga
Evercore ISI upgrades Doximity stock to Outperform on growth potential - Investing.com Australia
Evercore ISI upgrades Doximity stock to Outperform on growth potential By Investing.com - Investing.com Nigeria
Finanzdaten der Doximity Inc-Aktie (DOCS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.63%
0.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):